Precision Medicine Market Size, Share, Growth, Trends Market Report (2023-2032) DataHorizzon Research reports that the precision medicine market reached a valuation of USD 75.2 Billion in 2022 and is projected to grow to USD 174.8 Billion by 2032, demonstrating a compound annual growth rate (CAGR) of 8.9%. Read More: https://www.globenewswire.com/news-release/2023/10/09/2756741/0/en/Exploring-Precision-Medicine-Market-Growth-and-Opportunities-Market-Size-To-Reach-Surpass-USD-174-8-Billion-By-2032-Says-DataHorizzon-Research.html Precision medicine represents a tailored medical approach that incorporates various factors such as environmental influences, genetic makeup, and behavioral patterns in disease prevention and diagnosis. This approach facilitates disease prediction, precise medication prescription, and accurate diagnosis. Furthermore, precision medicine plays a vital role in streamlining pharmaceutical clinical trials by reducing time, costs, and failure rates. It is widely employed in detecting chromosomal abnormalities in cancer, guiding treatment for chronic conditions, and assessing the likelihood of hereditary genetic disorders passing on to future generations.